Author: Davis, Andrew M.; St-Gallay, Stephen A.; Kleywegt, Gerard J.
Title: Limitations and lessons in the use of X-ray structural information in drug design Cord-id: 52hfgz7t Document date: 2008_8_27
ID: 52hfgz7t
Snippet: The use of X-ray crystal structure models continues to provide a strong stimulus to drug discovery, through the direct visualisation of ligand–receptor interactions. There is sometimes a limited appreciation of the uncertainties introduced during the process of deriving an atomic model from the experimentally observed electron density. Here, some of these uncertainties are highlighted with recent examples from the literature, together with snippets of advice for the medicinal chemist embarking
Document: The use of X-ray crystal structure models continues to provide a strong stimulus to drug discovery, through the direct visualisation of ligand–receptor interactions. There is sometimes a limited appreciation of the uncertainties introduced during the process of deriving an atomic model from the experimentally observed electron density. Here, some of these uncertainties are highlighted with recent examples from the literature, together with snippets of advice for the medicinal chemist embarking on using X-ray crystal structure information in a drug discovery programme.
Search related documents:
Co phrase search for related documents- acetic acid and acid chain: 1
- acetic acid and active site: 1, 2
- acid chain and active site: 1
Co phrase search for related documents, hyperlinks ordered by date